跳到正文

Ikarian Capital, LLC 13F 持仓 · 2026年Q2

Ikarian Capital 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 126 只证券,申报市值合计 9.28 亿美元。前几大持仓:ABVX(13.16%)、IONS(5.98%)、KOD(5.36%)。本季前 25 大持仓中:新建仓 5 只、增持 9 只、减持 10 只。

排名代码公司市值占组合股数变动
1ABVXABIVAX SA$122.1M13.16%919,735增持
2IONSIONIS PHARMACEUTICALS INC$55.5M5.98%700,000增持
3KODKODIAK SCIENCES INC$49.8M5.36%1.3M减持
4XBISPDR SERIES TRUST$47.5M5.11%300,000减持
5ALMSALUMIS INC$34.5M3.72%1.2M减持
6PRAXPRAXIS PRECISION MEDICINES I$31.4M3.38%93,742增持
7MRNAMODERNA INC$28.0M3.02%400,000新建仓
8CAPRCAPRICOR THERAPEUTICS INC$23.0M2.48%954,215增持
9ANIPANI PHARMACEUTICALS INC$22.5M2.43%272,085减持
10PCVXVAXCYTE INC$22.6M2.43%388,682减持
11CLDXCELLDEX THERAPEUTICS INC NEW$22.0M2.38%592,500增持
12TENXTENAX THERAPEUTICS INC$17.1M1.85%1.2M增持
13VERAVERA THERAPEUTICS INC$16.4M1.76%381,700增持
14RCUSARCUS BIOSCIENCES INC$15.6M1.68%504,559新建仓
15RLMDRELMADA THERAPEUTICS INC$14.9M1.60%2.1M减持
16COGTCOGENT BIOSCIENCES INC$14.3M1.54%370,084新建仓
17NAMSWNEWAMSTERDAM PHARMA COMPANY$13.6M1.46%400,000新建仓
18CTNMCONTINEUM THERAPEUTICS INC$13.2M1.43%807,874持平
19CCCCC4 THERAPEUTICS INC$11.4M1.22%2.4M新建仓
20MAZEMAZE THERAPEUTICS INC$11.3M1.22%378,999减持
21ARWRARROWHEAD PHARMACEUTICALS IN$11.3M1.21%138,278增持
22BHVNBIOHAVEN LTD$11.1M1.20%748,181增持
23ANROALTO NEUROSCIENCE INC$10.7M1.16%407,338减持
24CNTBCONNECT BIOPHARMA HLDGS LTD$10.8M1.16%4.5M减持
25PHVSPHARVARIS N V$10.7M1.15%308,856减持

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR